Cargando…
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
To date, no targeted drugs, antibodies or combinations of chemotherapeutics have been demonstrated to be more efficient than temozolomide, or to increase efficacy of standard therapy (surgery, radiotherapy, temozolomide, steroid dexamethasone). According to recent phase III trials, standard therapy...
Autores principales: | Stepanenko, Aleksei A., Chekhonin, Vladimir P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316815/ https://www.ncbi.nlm.nih.gov/pubmed/30563098 http://dx.doi.org/10.3390/cancers10120492 |
Ejemplares similares
-
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?
por: Naumenko, Victor A., et al.
Publicado: (2022) -
An Unforeseen Glimmer of Hope
por: Samprathi, Madhusudan
Publicado: (2020) -
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
por: Simpson, Guy R, et al.
Publicado: (2016) -
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response
por: Stavrakaki, Eftychia, et al.
Publicado: (2021) -
Glimmers of hope on the Ebola front
Publicado: (2014)